Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
30803
CAS Number:
82410-32-0
Ganciclovir
Grade:
Meets USP specification
Purity:
≥ 98 % (HPLC)
Synonym(s):
9-(1,3-dihydroxy-2-propoxyméthyl)guanine, 2-Amino-1,9-dihydro-9-[[2-hydroxy-1-(hydroxyméthyl)éthoxy]méthyl]-6H-purine-6-one
Documents
$22.03 /1G
Taille
Request Bulk Quote
Informations sur le produit

Ganciclovir is an antiviral medication primarily used in the treatment of cytomegalovirus (CMV) infections, particularly in immunocompromised patients such as those undergoing organ transplantation or with HIV/AIDS. This compound acts by inhibiting viral DNA synthesis, making it a crucial therapeutic agent in managing CMV retinitis and preventing CMV disease in at-risk populations. Its effectiveness in reducing viral load and preventing complications associated with CMV infections highlights its importance in clinical settings.

In addition to its primary use, Ganciclovir is also being explored for its potential applications in other viral infections and as a research tool in virology studies. Its unique structure allows for targeted action against viral replication, providing a significant advantage over other antiviral agents. Researchers and healthcare professionals appreciate Ganciclovir for its ability to improve patient outcomes in challenging cases, making it a vital component in antiviral therapy.

Numéro CAS 
82410-32-0
Formule moléculaire
C9H13N5O4
Poids moléculaire 
255.23
Point de fusion 
251 - 256 ?C (Lit.)
Informations générales
Numéro CAS 
82410-32-0
Formule moléculaire
C9H13N5O4
Poids moléculaire 
255.23
Point de fusion 
251 - 256 ?C (Lit.)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Ganciclovir is widely utilized in research focused on:

  • Antiviral Treatments: Primarily used in the treatment of cytomegalovirus (CMV) infections, especially in immunocompromised patients, such as those undergoing organ transplants or with HIV/AIDS.
  • Research in Viral Pathogenesis: Employed in laboratory studies to understand the mechanisms of CMV and other herpesviruses, aiding in the development of new antiviral therapies.
  • Pharmaceutical Development: Acts as a key compound in the formulation of antiviral medications, allowing researchers to explore combination therapies that enhance efficacy against resistant viral strains.
  • Diagnostic Applications: Utilized in the development of diagnostic tests for CMV, helping healthcare professionals to quickly identify infections and tailor treatment plans.
  • Gene Therapy Research: Investigated for its potential in gene therapy applications, where it may be used to deliver therapeutic genes to target cells, enhancing treatment options for various genetic disorders.

Citations